^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
AmoyDx® KRAS/NRAS Mutations Detection Kit

Type:
CE Marked
Related tests:
Evidence

News

2years
Predictive value of KRAS/NRAS, IL-4 VNTR and HPV alterations in metastases of colorectal cancer. (PubMed, Bratisl Lek Listy)
Our study comprehensively and concomitantly evaluated several potential molecular risk factors. Future studies designed in such combined approaches will substantially contribute to better manage colorectal cancer tumorigenesis from molecular biological perspective (Tab. 6, Fig. 2, Ref. 40).
Journal
|
KRAS (KRAS proto-oncogene GTPase) • NRAS (Neuroblastoma RAS viral oncogene homolog) • KIT (KIT proto-oncogene, receptor tyrosine kinase) • IL4 (Interleukin 4)
|
NRAS mutation • KRAS G12D • RAS wild-type • KRAS G12 • NRAS wild-type • NRAS G12D • NRAS G12
|
AmoyDx® KRAS/NRAS Mutations Detection Kit
4years
Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancer. (PubMed, Turk J Med Sci)
"It can be inferred from this study that Tunisian CRC patients have a similar frequency of KRAS and NRAS mutations compared to those observed in other populations. Consequently, screening for KRAS and NRAS mutation is crucial to orientate the therapies and the selection of an appropriate candidate, avoiding patients? unnecessary toxicity and costs."
Journal • Clinical
|
EGFR (Epidermal growth factor receptor) • KRAS (KRAS proto-oncogene GTPase) • NRAS (Neuroblastoma RAS viral oncogene homolog)
|
KRAS mutation • NRAS mutation • KRAS G12D • KRAS G12V • KIT mutation • KRAS G12A • KRAS G12 • KRAS G13 • KRAS exon 2 mutation • NRAS G12D • NRAS G13
|
AmoyDx® KRAS/NRAS Mutations Detection Kit